These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36602311)

  • 1. Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses.
    Alsenani TA; Rodríguez MM; Ghiglione B; Taracila MA; Mojica MF; Rojas LJ; Hujer AM; Gutkind G; Bethel CR; Rather PN; Introvigne ML; Prati F; Caselli E; Power P; van den Akker F; Bonomo RA
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0093022. PubMed ID: 36602311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
    Nguyen NQ; Krishnan NP; Rojas LJ; Prati F; Caselli E; Romagnoli C; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1760-6. PubMed ID: 26729491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
    Rojas LJ; Taracila MA; Papp-Wallace KM; Bethel CR; Caselli E; Romagnoli C; Winkler ML; Spellberg B; Prati F; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1751-9. PubMed ID: 26729496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from
    Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM
    ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985
    [No Abstract]   [Full Text] [Related]  

  • 5. Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226.
    Ke W; Bethel CR; Papp-Wallace KM; Pagadala SR; Nottingham M; Fernandez D; Buynak JD; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2012 May; 56(5):2713-8. PubMed ID: 22330909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis and Binding Kinetics of Vaborbactam in Class A β-Lactamase Inhibition.
    Pemberton OA; Tsivkovski R; Totrov M; Lomovskaya O; Chen Y
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32778546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.
    Powers RA; Swanson HC; Taracila MA; Florek NW; Romagnoli C; Caselli E; Prati F; Bonomo RA; Wallar BJ
    Biochemistry; 2014 Dec; 53(48):7670-9. PubMed ID: 25380506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.
    Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D
    J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
    Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical Activity of Vaborbactam.
    Tsivkovski R; Lomovskaya O
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.
    Hinchliffe P; Tooke CL; Bethel CR; Wang B; Arthur C; Heesom KJ; Shapiro S; Schlatzer DM; Papp-Wallace KM; Bonomo RA; Spencer J
    mBio; 2022 Jun; 13(3):e0179321. PubMed ID: 35612361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
    Ke W; Sampson JM; Ori C; Prati F; Drawz SM; Bethel CR; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2011 Jan; 55(1):174-83. PubMed ID: 21041505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.
    Ishikawa T; Furukawa N; Caselli E; Prati F; Taracila MA; Bethel CR; Ishii Y; Shimizu-Ibuka A; Bonomo RA
    Front Microbiol; 2021; 12():720036. PubMed ID: 34970229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Vahabi R; Taracila MA; Bonomo RA; Prati F
    J Med Chem; 2015 Jul; 58(14):5445-58. PubMed ID: 26102369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs.
    Introvigne ML; Taracila MA; Prati F; Caselli E; Bonomo RA
    ChemMedChem; 2020 Jul; 15(14):1283-1288. PubMed ID: 32459878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.